» Articles » PMID: 23279883

Expansion of Autoreactive Unresponsive CD21-/low B Cells in Sjögren's Syndrome-associated Lymphoproliferation

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2013 Jan 3
PMID 23279883
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Primary Sjögren's syndrome (SS) is an autoimmune disease associated with a high risk of developing non-Hodgkin's lymphoma. This study was undertaken to determine the nature of B cells driving lymphoproliferation in primary SS.

Methods: B cell subsets and function were analyzed in peripheral blood from 66 adult patients with primary SS (including 14 patients with B cell lymphoproliferative disease [LPD]) and 30 healthy donors, using flow cytometry, calcium mobilization, and gene array analysis. The reactivity of recombinant antibodies isolated from single B cells from patients with primary SS and LPD was tested using an enzyme-linked immunosorbent assay.

Results: We observed an expansion of an unusual CD21-/low B cell population that correlated with lymphoproliferation in patients with primary SS. A majority of CD21-/low B cells from patients with primary SS expressed autoreactive antibodies, which recognized nuclear and cytoplasmic structures. These B cells belonged to the memory compartment, since their Ig genes were mutated. They were unable to induce calcium flux, become activated, or proliferate in response to B cell receptor and/or CD40 triggering, suggesting that these autoreactive B cells may be anergic. However, CD21-/low B cells from patients with primary SS remained responsive to Toll-like receptor (TLR) stimulation. Molecules specifically expressed in CD21-/low B cells that are likely to induce their unresponsive stage were detected in gene array analyses.

Conclusion: Patients with primary SS who display high frequencies of autoreactive and unresponsive CD21-/low B cells are susceptible to developing lymphoproliferation. These cells remain in peripheral blood controlled by functional anergy instead of being eliminated, and chronic antigenic stimulation through TLR stimulation may create a favorable environment for breaking tolerance and activating these cells.

Citing Articles

CD21 B cells reveal a unique glycosylation pattern with hypersialylation and hyperfucosylation.

Felixberger P, Andrieux G, Maul-Pavicic A, Goldacker S, Harder I, Gutenberger S Front Immunol. 2025; 16:1512279.

PMID: 40013136 PMC: 11861550. DOI: 10.3389/fimmu.2025.1512279.


Aberrant B cell receptor signaling responses in circulating double-negative 2 B cells from radiographic axial spondyloarthritis patients.

Wilbrink R, Neys S, Hendriks R, Spoorenberg A, Kroese F, Corneth O J Transl Autoimmun. 2025; 10:100270.

PMID: 39974741 PMC: 11835616. DOI: 10.1016/j.jtauto.2025.100270.


Sex-specific differences in primary Sjögren's disease.

Punnanitinont A, Kramer J Front Dent Med. 2025; 4:1168645.

PMID: 39916928 PMC: 11797869. DOI: 10.3389/fdmed.2023.1168645.


Know Your ABCs: Discovery, Differentiation, and Targeting of T-Bet+ B Cells.

Winslow G, Levack R Immunol Rev. 2025; 330(1):e13440.

PMID: 39844597 PMC: 11754996. DOI: 10.1111/imr.13440.


Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection.

Kuijper L, Kreher C, Elias G, Claireaux M, Kerster G, Bos A Front Immunol. 2025; 15:1505719.

PMID: 39742271 PMC: 11686410. DOI: 10.3389/fimmu.2024.1505719.


References
1.
Lopez F, Textoris J, Bergon A, Didier G, Remy E, Granjeaud S . TranscriptomeBrowser: a powerful and flexible toolbox to explore productively the transcriptional landscape of the Gene Expression Omnibus database. PLoS One. 2008; 3(12):e4001. PMC: 2602602. DOI: 10.1371/journal.pone.0004001. View

2.
Fujimoto M, Sato S . B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity. J Dermatol Sci. 2007; 46(1):1-9. DOI: 10.1016/j.jdermsci.2006.12.004. View

3.
Charles E, Brunetti C, Marukian S, Ritola K, Talal A, Marks K . Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. Blood. 2011; 117(20):5425-37. PMC: 3109715. DOI: 10.1182/blood-2010-10-312942. View

4.
Wehr C, Eibel H, Masilamani M, Illges H, Schlesier M, Peter H . A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol. 2004; 113(2):161-71. DOI: 10.1016/j.clim.2004.05.010. View

5.
Wardemann H, Yurasov S, Schaefer A, Young J, Meffre E, Nussenzweig M . Predominant autoantibody production by early human B cell precursors. Science. 2003; 301(5638):1374-7. DOI: 10.1126/science.1086907. View